LLLydia A. Luu

Lydia A. Luu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lydia A. Luu has a total of 38 co-authors. Here are the top co-authors by number of shared publications:

  • Barrett J. Zlotoff

    Department of Dermatology University of Virginia Medical Center Charlottesville Virginia USA

    4 shared publications
  • Richard Hal Flowers

    Department of Dermatology, University of Virginia, Charlottesville, USA

    3 shared publications
  • Ann L. Kellams

    Affiliation Division of General Pediatrics, Department of Pediatrics, University of Virginia, Charlottesville, Virginia, United States of America

    2 shared publications
  • DeVon C. Preston

    Affiliation Division of Allergy and Immunology, Department of Pediatrics and Internal Medicine, University of Virginia, Charlottesville, Virginia, United States of America

    2 shared publications
  • Julia A. Wisniewski

    Affiliation Division of Allergy and Immunology, Department of Pediatrics and Internal Medicine, University of Virginia, Charlottesville, Virginia, United States of America

    2 shared publications
  • Mark Russell

    Department of Dermatology, University of Virginia, Charlottesville, USA

    2 shared publications

Latest Publications

  • Sliding Z-Plasty for Alignment of the Vermilion Border During Vertical Lip Repairs

    by Jessica Padniewski, Lydia A. Luu, Igor Kapetanovic, Ian A. Maher

    Was not provided for this article.

  • Open Access

    Patterns of keratinocyte carcinoma incidence on the scalp and forehead of non-alopecic women: a retrospective review

    by Lydia A. Luu, Wendy Novicoff, Julian Stashower, Seth Martin, Mark Russell

    Keratinocyte carcinomas are the most frequently diagnosed form of malignancy, and ultraviolet radiation exposure is a primary risk factor. Human head hair offers some protection from ultraviolet radiation, and women often wear hairstyles that result in variable scalp exposure to sunlight. The distribution of keratinocyte carcinomas of the forehead and scalp of women has not been previously studied. To better characterize the incidence and distribution of keratinocyte carcinomas on the scalp and forehead of non-alopecic females, a retrospective chart review was performed of keratinocyte carcinomas diagnosed and treated at a single tertiary care center between July 2017 and October 2021. Tumor and patient characteristics were compiled and analyzed. 302 cases of keratinocyte carcinomas occurring on the scalp and forehead of non-alopecic women were identified. Basal cell carcinoma occurred at a higher rate than squamous cell carcinoma (231 vs. 71). Both basal cell carcinomas and squamous cell carcinomas were more likely to occur within the part line on the scalp (p = 0.036). There was also an increased risk of developing keratinocyte carcinomas on the upper third of the forehead, although this observation did not reach statistical significance (p = 0.165). Keratinocyte carcinomas of the scalp and forehead are more likely to occur in the part line of the scalp. This information can guide dermatologists during clinical exams and when counseling patients on performing proper sun-protective measures.

  • Open Access

    A Growing Pink Periorbital Papule in a Middle‐Aged Man: A Clinicopathological Challenge

    by Lydia A. Luu, Linglei Ma, Mark Russell

    This report describes a case of a 48‐year‐old man who presented with a slowly enlarging lesion on the right lower eyelid that had been present for 8–9 years. The skin biopsy revealed an apocrine carcinoma of the eyelid. We discuss the clinical and histopathological differential diagnosis of apocrine carcinoma, along with treatment recommendations for these tumors.

  • Open Access

    Violaceous Nodules on the Left Forearm of an Immunosuppressed Patient Following Heart Transplantation for Cardiac Amyloidosis

    by Zachary Corey, Lydia A. Luu, Sabrina Newman, Shyam S. Raghavan

    We present the case of a 60-year-old immunocompromised man who presented with two pruritic pink–red indurated nodules with overlying scale and focal areas of ulceration on his left dorsal and left medial forearm, which evolved over a 2-month period. The pathology showed numerous fungal hyphae present that were pauci-septate with various branched angles and variable hyphal thickness. Fungal cultures grew Rhizopus species and a universal fungal PCR detected the Rhizopus oryzae complex. Based on the clinicopathologic correlation, the diagnosis of cutaneous mucormycosis was made. Cutaneous mucormycosis is an aggressive fungal infection of the Mucorales family occurring after the inoculation of fungal spores in disrupted skin. It usually presents as a necrotic eschar but can also present as cellulitis that evolves into a necrotic ulcer. A prompt diagnosis is critical for the effective management of cutaneous mucormycosis. The treatment includes an immediate systemic treatment with amphotericin B and a surgical debridement of the necrotic regions. Given the wide range of presenting symptoms, clinical suspicion for this emergent condition must remain high in immunocompromised and diabetic patients.

  • Open Access

    Rare Case of Vasculitis Induced by Crusted Scabies Infection

    by Catherine Lyons, Lydia Luu, Seth Martin, Olivia Schenck

    Here we present a 70-year-old man who presented with a rare case of cutaneous leukocytoclastic vasculitis (LCV) secondary to a crusted scabies (Sarcoptes scabiei var hominis) mite infestation. Few cases have been reported in the literature of LCV in association with scabies as LCV is typically caused by a bacterial or viral infection or other malignancy. Since this combination of cutaneous manifestations is rare, diagnosis and treatment may be delayed, allowing for the development of advanced disease.

  • Open Access

    Erosive Pustular Dermatosis of the Scalp Treated with Serial Debridement: Case Report

    by Brenna Douthitt, Lydia Luu, Richard Flowers

    An 82-year-old man with a past medical history of numerous non-melanoma skin cancers (NMSCs), including unresectable squamous cell carcinoma of the right temple treated with radiation therapy and cemiplimab, presented with worsening erosive pustular dermatosis of the scalp (EPDS). This had initially onset four years prior in the setting of 5-fluorouracil and photodynamic therapy for actinic keratoses. He had failed topical ultra-potent steroids, tacrolimus, and dapsone as well as oral dapsone, doxycycline, and acitretin. The condition’s chronicity and radiation to the area likely exacerbated his EPDS. We pursued serial debridement, followed by clobetasol propionate 0.05% ointment twice daily. The patient reported marked improvement with stable condition between treatments. Upon better control of his EPDS, a suspicious ulcerative lesion under a previously affected area was identified and biopsied, revealing atypical fibroxanthoma. EPDS is an inflammatory dermatosis characterized by pustules, erosions, and crusting, often caused by sun damage, local trauma, and topical medications. First-line treatment is topical corticosteroids. We show that serial debridement is effective for treating recalcitrant EPDS. We emphasize the importance of maintaining adequate control of EPDS to avoid masking suspicious lesions, as the patient demographic affected by EPDS is at high risk for NMSCs.

  • Open Access

    Diffuse xanthomas in a patient with lipoprotein X hyperlipidemia

    by Katherine Grace Byrnes, Scott Berg, Lydia Luu, Lisa Borretta, Richard Hal Flowers

  • Widespread livedo racemosa

    by Patricia Zhao, Lydia A Luu, Tappy J Gish, Shyam S Raghavan, Alejandro A Gru, Barrett J Zlotoff

    A 41-year-old woman with monoclonal gammopathy of undetermined significance presented with a 1-year history of livedo racemosa that started on one arm after receiving the Pfizer BioNTech COVID-19 vaccine. Her primary care physician initially thought it was a benign reaction to the COVID-19 vaccine as her symptoms were on the same arm as the site of injection. However, the livedo racemosa subsequently became more widespread after COVID-19 infection.

  • Open Access

    Palmar telangiectasias in a 4‐year‐old girl

    by Erica J. Mark, Lydia A. Luu, Barrett J. Zlotoff

  • Open Access

    Apple cider vinegar soaks do not alter the skin bacterial microbiome in atopic dermatitis

    by Lydia A. Luu, Richard H. Flowers, Yingnan Gao, Martin Wu, Sofia Gasperino, Ann L. Kellams, DeVon C. Preston, Barrett J. Zlotoff, Julia A. Wisniewski, Steven L. Zeichner

    Introduction: Atopic dermatitis is a common skin disease characterized by altered cutaneous immunity in which patients often exhibit lower skin microbiota diversity compared to healthy skin and are prone to colonization by Staphylococcus aureus. Apple cider vinegar has been shown to have antibacterial effects; however, its effects on the skin microbiome have not previously been well-described. Objectives: We aimed to examine the effects of topical dilute apple cider vinegar soaks on Staphylococcus aureus abundance, skin bacterial microbiome composition, and skin bacterial microbiome diversity in atopic dermatitis participants compared to healthy skin. Methods: Eleven subjects with atopic dermatitis and 11 healthy controls were enrolled in this randomized, non-blinded, single-institution, split-arm pilot study. Subjects soaked one forearm in dilute apple cider vinegar (0.5% acetic acid) and the other forearm in tap water for 10 minutes daily. Skin bacteria samples were collected from subjects’ volar forearms before and after 14 days of treatment. 16S sequencing was used to analyze Staphylococcus aureus abundance and skin bacterial microbiome composition, and alpha diversity of microbiota were determined using Shannon diversity index. Results: There was no difference in skin bacterial microbiome in atopic dermatitis subjects after 2 weeks of daily water or apple cider vinegar treatments (p = 0.056 and p = 0.22, respectively), or in mean abundance of S. aureus on apple cider vinegar-treated forearms (p = 0.60). At 2 weeks, the skin bacterial microbiomes of healthy control subjects were not significantly different from the skin bacterial microbiome of atopic dermatitis subjects (p = 0.14, 0.21, 0.12, and 0.05). Conclusions: Our results suggest that daily soaks in 0.5% apple cider vinegar are not an effective method of altering the skin bacterial microbiome in atopic dermatitis. Further studies are needed to explore the effects of different concentrations of apple cider vinegar on skin microflora and disease severity. Trial number: UVA IRB-HSR #19906.